
Sign up to save your podcasts
Or


In today's episode of the Innovation series, Dr. Parikh sits down with Mindy Mintz Mordecai, president and CEO of the Esophageal Cancer Action Network (ECAN). They discuss Mindy's journey, the origins of ECAN, and how it continues to support current and future patients with esophageal cancer. Today's episode was brought to you by Castle Biosciences, maker of TissueCypher, a test designed to predict the risk of esophageal cancer in patients with Barrett's esophagus.
By Neil D. Parikh, MD4.9
6262 ratings
In today's episode of the Innovation series, Dr. Parikh sits down with Mindy Mintz Mordecai, president and CEO of the Esophageal Cancer Action Network (ECAN). They discuss Mindy's journey, the origins of ECAN, and how it continues to support current and future patients with esophageal cancer. Today's episode was brought to you by Castle Biosciences, maker of TissueCypher, a test designed to predict the risk of esophageal cancer in patients with Barrett's esophagus.

43,628 Listeners

23,458 Listeners

171,952 Listeners

696 Listeners

7,201 Listeners

112,333 Listeners

31 Listeners

1,458 Listeners

368,611 Listeners

9,245 Listeners

85 Listeners

26 Listeners

11,677 Listeners

2,061 Listeners

13 Listeners